Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
7PrzEuK9HfffzznM